G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation

Bone Marrow Transplantation

Volumn 42, Issue 11, 2008, Pages 733-737

  Seshadri, T ^a   Al Farsi, K ^a   Stakiw, J ^b   Ma, C ^a   Saragosa, R ^a   Franke, N ^a   Keating, A ^a   Crump, M ^a   Kuruvilla, J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RADIATION DOSE; STEM CELL MOBILIZATION; SURVIVAL RATE; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADULT; AGED; BONE MARROW TRANSPLANTATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; STEM CELLS; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149473086     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.249     Document Type: Article

References (14)

1. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
2. Jansen J, Thompson JM, Dugan MJ, Nolan P, Wiemann MC, Birhary R et al Peripheral blood progenitor cell transplantation. Ther Apher 2002; 6: 5-14.
3. Stiff PJ. Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999; 23 (Suppl 2): S29-S33.
4. Weaver CH, Tauer K, Zhen B, Schwartzberg LS, Hazelton B, Weaver Z et al. Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields. J Hematother 1998; 7: 241-249.
5. Lemoli RM, de Vivo A, Damiani D, Isidori A, Tani M, Bonini A et al Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood 2003; 102: 1595-1600.
6. Damiani D, Fanin R, Silvestri F, Grimaz S, Infanti L, Geromin A et al Randomized trial of autologous filgrastimprimed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 1997; 90: 36-42.
7. Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B et al Cytokine-primed bone marrow stem cells vs peripheral blood stem cells for autologous transplantation: A randomized comparison of GM-CSF vs G-CSF. Biol Blood Marrow Transplant 1997; 3: 217-223.
8. al-Fiar F, Prince HM, Imrie K, Stewart AK, Crump M, Keating A. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: Value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay. Cell Transplant 1997; 6: 491-495.
9. Elfenbein GJ, Sackstein R. Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 2004; 32: 327-339.
10. Kozuka T, Ikeda K, Teshima T, Yoshida C, Shinagawa K, Kojima K et al Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors. Transfusion 2004; 44: 526-532.
11. Lapidot T, Petit I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30: 973-981.
12. Steidl U, Kronenwett R, Rohr U-P, Fenk R, Kliszewski S, Maercker C et al. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood 2002; 99: 2037-2044.
13. Cashen AF, Nervi B, DiPersio J. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol 2007; 3: 19-27.
14. Calandra G, McCarty J, McGuirk J, Tricot G, Crocker S, Badel K et al AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: Compassionate use data. Bone Marrow Transplant 2007; 41: 331-338.